• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX, INC. PREVI ISOLA; PREVI® ISOLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX, INC. PREVI ISOLA; PREVI® ISOLA Back to Search Results
Model Number 29500
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of experiencing an issue in which a cps media plate was mislabeled as a pvx media plate in association with their previ® isola instrument (ref 29500, serial (b)(4) while using previ® isola zebra label roll (ref 416198, lot 515603).The customer was processing vaginal samples on pvx and anc media when they noticed that one of the pvx plates did not have a label attached to it.Later, while processing urine samples on cps media, the customer found a cps plate with a pvx label on it.The customer confirmed that the cps plate did not have two labels affixed (cps and pvx), but rather just one incorrect label.The customer did not know exactly where the mislabeled cps plate was in the series of urine samples that were processed.The customer also indicated that 7 or 8 vaginal samples were processed between the pvx plate without the label and the cps plate with the pvx label.Since the customer was concerned that the labels for the rest of the cps plates may have been shifted by one plate, the customer decided to manually reseed the rest of the urine samples.There is no indication or report from the customer that this event led to any adverse event related to any patient's state of health.A biomérieux internal investigation has been initiated.
 
Manufacturer Narrative
Biomérieux investigation was conducted in response to multiple customer complaints reported against 416198 (previ isola zebra label rolls) lots #515303 and #515603.The complaints indicate that the labels remain attached to the liner material, and are not released from the rolls and adhered to the plates during previ® isola processing.The investigation identified: 1.Material 416198 was not "storage controlled" during transit from idc/subsidiary/distributor warehouse to another idc/subsidiary/distributor.2.France idc does not monitor/maintain warehouse humidity.Despite this, the two (2) impacted lots (#515303 and #515603) were shipped worldwide, with the majority of the customer complaints originating in france.The root cause for 416198 labels randomly sticking to the roll liner could not be determined.There were no changes in manufacturing for the two (2) impacted lots (#515303 and #515603) since the release of the 416198 rev b on 23may2014, and no changes in the product vendor since 28oct2013.Material 416198 rev c was released on 12-jan-2021 with a new adhesive (fasson at2550).There has been no systemic issue with the new adhesive applied to the label roll.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PREVI ISOLA
Type of Device
PREVI® ISOLA
Manufacturer (Section D)
BIOMÉRIEUX, INC.
595 anglum road
hazelwood MO 63042
MDR Report Key11345147
MDR Text Key252783565
Report Number1950204-2021-00016
Device Sequence Number1
Product Code LXG
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number29500
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/22/2021
Initial Date FDA Received02/18/2021
Supplement Dates Manufacturer Received08/19/2021
Supplement Dates FDA Received08/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-